| scholarly article | Q13442814 |
| P50 | author | Luis Villacorta | Q42428596 |
| P2093 | author name string | Y Eugene Chen | |
| Bruce A Freeman | |||
| Zhen Gao | |||
| Francisco J Schopfer | |||
| P2860 | cites work | miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 | Q83034995 |
| Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo. | Q50774975 | ||
| Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. | Q51763432 | ||
| The nitrated fatty acid 10-nitro-oleate attenuates allergic airway disease. | Q53095793 | ||
| Activation of TRPC channels contributes to OA-NO2-induced responses in guinea-pig dorsal root ganglion neurons. | Q53832347 | ||
| PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties | Q57244208 | ||
| Hypoxia Inducible Factor–Dependent Regulation of Angiogenesis by Nitro–Fatty Acids | Q59754259 | ||
| Reactive oxygen species in human health and disease | Q73590209 | ||
| Evaluation of nitroalkenes as nitric oxide donors | Q79707306 | ||
| Modulation of nitrated lipid signaling by multidrug resistance protein 1 (MRP1): glutathione conjugation and MRP1-mediated efflux inhibit nitrolinoleic acid-induced, PPARgamma-dependent transcription activation | Q79752009 | ||
| Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice | Q80576638 | ||
| Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. | Q24606271 | ||
| Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health | Q24618018 | ||
| Inflammation, immunity, and hypertensive end-organ damage | Q26827525 | ||
| Molecular recognition of nitrated fatty acids by PPARγ | Q27651047 | ||
| Redox-dependent anti-inflammatory signaling actions of unsaturated fatty acids | Q28386488 | ||
| Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase | Q28387540 | ||
| The electrophile responsive proteome: integrating proteomics and lipidomics with cellular function | Q28388959 | ||
| Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide | Q29547245 | ||
| Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance | Q29614354 | ||
| Convergence of nitric oxide and lipid signaling: anti-inflammatory nitro-fatty acids. | Q30374785 | ||
| Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators | Q30480974 | ||
| Nitro-oleic acid downregulates lipoprotein-associated phospholipase A2 expression via the p42/p44 MAPK and NFκB pathways | Q33585468 | ||
| Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation | Q33632763 | ||
| Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids. | Q33639171 | ||
| Nitrate and nitrite in biology, nutrition and therapeutics | Q33685139 | ||
| Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics. | Q33702016 | ||
| Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice | Q33727789 | ||
| Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment | Q33746493 | ||
| Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions | Q33782620 | ||
| Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice. | Q33803709 | ||
| Inflammation and its resolution as determinants of acute coronary syndromes | Q33834800 | ||
| Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand | Q33849597 | ||
| Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension | Q33881508 | ||
| Nitro-oleic acid inhibits firing and activates TRPV1- and TRPA1-mediated inward currents in dorsal root ganglion neurons from adult male rats | Q33890925 | ||
| Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension | Q33898213 | ||
| Nitrite treatment rescues cardiac dysfunction in aged mice treated with conjugated linoleic acid | Q33938970 | ||
| Platelets and their chemokines in atherosclerosis-clinical applications | Q34019069 | ||
| Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats | Q34021895 | ||
| Nitroalkenes confer acute cardioprotection via adenine nucleotide translocase 1. | Q34096582 | ||
| A cell-based phenotypic assay to identify cardioprotective agents | Q34186419 | ||
| Macrophages in atherosclerosis: a dynamic balance. | Q34368005 | ||
| Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity | Q34414890 | ||
| Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages | Q34512881 | ||
| Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins | Q34522097 | ||
| Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression | Q34573108 | ||
| Nitroarachidonic acid, a novel peroxidase inhibitor of prostaglandin endoperoxide H synthases 1 and 2. | Q34787024 | ||
| Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism | Q34800018 | ||
| Electrophilic fatty acids regulate matrix metalloproteinase activity and expression. | Q34963415 | ||
| Detection and quantification of protein adduction by electrophilic fatty acids: mitochondrial generation of fatty acid nitroalkene derivatives. | Q35129775 | ||
| Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival | Q35187029 | ||
| Novel proresolving aspirin-triggered DHA pathway | Q35189668 | ||
| Nitrooleic acid protects against cisplatin nephropathy: role of COX-2/mPGES-1/PGE2 cascade | Q35227002 | ||
| Nitrooleic Acid Attenuates Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice. | Q35227098 | ||
| Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome. | Q35354138 | ||
| Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy | Q35535621 | ||
| Convergence of biological nitration and nitrosation via symmetrical nitrous anhydride | Q35756214 | ||
| Macrophage activation induces formation of the anti-inflammatory lipid cholesteryl-nitrolinoleate | Q35791844 | ||
| Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease | Q35791848 | ||
| Formation and signaling actions of electrophilic lipids | Q35804051 | ||
| Nitro-oleic acid targets transient receptor potential (TRP) channels in capsaicin sensitive afferent nerves of rat urinary bladder | Q35906650 | ||
| Generation and esterification of electrophilic fatty acid nitroalkenes in triacylglycerides | Q36190263 | ||
| Nitro-fatty acid reaction with glutathione and cysteine. Kinetic analysis of thiol alkylation by a Michael addition reaction | Q36316709 | ||
| Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway | Q36319949 | ||
| Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. | Q36339484 | ||
| Regio- and stereospecific syntheses and nitric oxide donor properties of (E)-9- and (E)-10-nitrooctadec-9-enoic acids | Q36347304 | ||
| Conjugated linoleic acid is a preferential substrate for fatty acid nitration | Q36492744 | ||
| Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands | Q36493003 | ||
| Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts. | Q36687046 | ||
| Nitroalkenes suppress lipopolysaccharide-induced signal transducer and activator of transcription signaling in macrophages: a critical role of mitogen-activated protein kinase phosphatase 1. | Q36796547 | ||
| Characterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine. | Q36920628 | ||
| Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury | Q36956739 | ||
| Modulation of nitro-fatty acid signaling: prostaglandin reductase-1 is a nitroalkene reductase | Q37132192 | ||
| Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: implications for cardioprotection | Q37176170 | ||
| PPARgamma and its ligands: therapeutic implications in cardiovascular disease. | Q37179467 | ||
| Co-treatment with conjugated linoleic acid and nitrite protects against myocardial infarction | Q37392069 | ||
| Discovery of the nitric oxide signaling pathway and targets for drug development | Q37409901 | ||
| Cardiovascular consequences when nitric oxide and lipid signaling converge | Q37412845 | ||
| Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice | Q37439729 | ||
| Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid | Q37446099 | ||
| Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion | Q37467857 | ||
| Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity | Q37591231 | ||
| Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD). | Q37622525 | ||
| Mitochondrially targeted nitro-linoleate: a new tool for the study of cardioprotection | Q37686281 | ||
| Novel aspects of dietary nitrate and human health | Q38103950 | ||
| Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes | Q38129182 | ||
| Dynamic Aspects of Macrophage Polarization during Atherosclerosis Progression and Regression | Q38271958 | ||
| Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis | Q38502138 | ||
| Cardio-Pulmonary-Renal Interactions: A Multidisciplinary Approach | Q38517250 | ||
| Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy | Q39645977 | ||
| PPARs and lipid ligands in inflammation and metabolism | Q41763780 | ||
| Nitro-fatty acid metabolome: saturation, desaturation, beta-oxidation, and protein adduction | Q41995295 | ||
| Nitro-oleic acid, a novel and irreversible inhibitor of xanthine oxidoreductase | Q42020038 | ||
| Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury | Q42027780 | ||
| Nitro-oleic acid inhibits angiotensin II-induced hypertension | Q42428542 | ||
| Nrf2 protects against maladaptive cardiac responses to hemodynamic stress | Q42456759 | ||
| Nitro-oleic acid is a novel anti-oxidative therapy for diabetic kidney disease | Q42756932 | ||
| Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP. | Q43826766 | ||
| The absence of macrophage Nrf2 promotes early atherogenesis | Q43901244 | ||
| Characterization of linoleic acid nitration in human blood plasma by mass spectrometry. | Q44108232 | ||
| Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells | Q44128021 | ||
| Cholesteryl nitrolinoleate, a nitrated lipid present in human blood plasma and lipoproteins | Q44499494 | ||
| Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. | Q45985589 | ||
| Specific GC-MS/MS stable-isotope dilution methodology for free 9- and 10-nitro-oleic acid in human plasma challenges previous LC-MS/MS reports | Q46151364 | ||
| Fatty acid transduction of nitric oxide signaling. Nitrolinoleic acid is a hydrophobically stabilized nitric oxide donor | Q46375494 | ||
| 6-Methylnitroarachidonate: a novel esterified nitroalkene that potently inhibits platelet aggregation and exerts cGMP-mediated vascular relaxation | Q46383370 | ||
| Nitrated lipids decompose to nitric oxide and lipid radicals and cause vasorelaxation | Q46617979 | ||
| Profiling and relative quantification of multiply nitrated and oxidized fatty acids | Q46722547 | ||
| P921 | main subject | fatty acid | Q61476 |
| P304 | page(s) | 873-889 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Frontiers in Bioscience | Q5506062 |
| P1476 | title | Nitro-fatty acids in cardiovascular regulation and diseases: characteristics and molecular mechanisms | |
| P478 | volume | 21 |
| Q92572638 | A FABP4-PPARγ signaling axis regulates human monocyte responses to electrophilic fatty acid nitroalkenes |
| Q36138738 | HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics |
| Q50056117 | In situ generation, metabolism and immunomodulatory signaling actions of nitro-conjugated linoleic acid in a murine model of inflammation. |
| Q52631728 | Inflammatory signaling and metabolic regulation by nitro-fatty acids. |
| Q55692383 | Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines. |
| Q39011349 | Nitro-fatty acids in plant signaling: New key mediators of nitric oxide metabolism |
| Q47301748 | Nitro-oleic acid (NO2OA) release enhances regional angiogenesis in a rat abdominal wall defect model. |
| Q97531874 | Suppression of Vascular Macrophage Activation by Nitro-Oleic Acid and its Implication for Abdominal Aortic Aneurysm Therapy |
| Q87858871 | Transcriptomic sequencing reveals diverse adaptive gene expression responses of human vascular smooth muscle cells to nitro-conjugated linoleic acid |
Search more.